World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Taking Risk for Profit, Industry Seeks Cancer Drugs
Keywords:
Tags:
The shift to finding new drugs for cancer. Pfizer has a development team of 10000 researchers in one location near San Diego, California, to develop new drugs for cancer even though some experts say the search for cancer drugs is devilishly complicated. The causes of cancer at the molecular level are complicated and vary even from person to person for the same cancer. Says one expert this also raises questions about the benefit to people as a large amount of resources are shifted to areas like cancer that affect fewer people than other diseases, and where the existing drugs have only prolonged life marginally, in some cases even as low as a few months at a huge cost of thousands of dollars. Tarceva for pancreatic cancer for example only prolongs life by 12 days at a cost of $3500 per month. 860 cancer drugs are being tested in clinical trials according to the trade group of the pharmaceutical industry. This is more than twice the number for heart disease and stroke, and nearly twice the number for AIDS and all other infdectious diseases combined, and nearly twice the number for Alzheimier's and all neurological dieases combined.
Changing marketing landscape for Drug Companies
10/02/2006
Controversial practices of some companies, Changes in the marketing strategies and practices of companies like Pfizer.
Grouped Articles
Glaxo Epilepsy Drug Is Linked to Defects Found in Newborns - WSJ.com
Wall Street Journal 10/02/2006
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/2006
Pfizer to Cut 20% Of U.S. Sales Force, Signaling End of Era - WSJ.com
Wall Street Journal 11/29/2006
AstraZeneca Vows to Work With FDA - WSJ.com
Wall Street Journal 11/28/2006
Cephalon Used Improper Tactics To Sell Drug, Probe Finds - WSJ.com
Wall Street Journal 11/21/2006
Taking Risk for Profit, Industry Seeks Cancer Drugs
New York Times 09/02/2009
Western pharmaceutical company growth strategies.
07/09/2007
As sales growth slows in developed countries, pricing drops, and drug development is weak, the search for new avenues for growth.
Grouped Articles
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
Glaxo to Weigh Results Of New Diet Pill
Wall Street Journal 10/24/2007
Prescription-Drug Sales Growth Is Expected to Slow
Wall Street Journal 11/01/2007
BusinessWeek 12/05/2007
Osteoporosis Drug Is Amgen's Hope For a Strong Future
Wall Street Journal 12/14/2007
Glaxo Becomes Master of Reinventing Drugs
Wall Street Journal 04/17/2008
The growing shift to cancer drugs research and development.
04/24/2009
860 drugs are at the clinical trial stage for cancer. The high prices for cancer drugs are part of the reason, and the lack of effective drugs makes it appear as an opportunity. But finding effective drugs has been elusive.
Grouped Articles
Taking Risk for Profit, Industry Seeks Cancer Drugs
New York Times 09/02/2009
Lack of Study Volunteers Hobbles Cancer Fight
New York Times 08/03/2009
In Push for Cancer Screening, Limited Benefits
New York Times 07/17/2009
Advances Elusive in the Drive to Cure Cancer
New York Times 04/24/2009
Search for new cancer drugs.
09/02/2009
Grouped Articles
Taking Risk for Profit, Industry Seeks Cancer Drugs
New York Times 09/02/2009
Cancer research and the the slow progress of much of the research.
04/24/2009
Grouped Articles
Grant System Leads Cancer Researchers to Play It Safe
New York Times 06/28/2009
Taking Risk for Profit, Industry Seeks Cancer Drugs
New York Times 09/02/2009
In Push for Cancer Screening, Limited Benefits
New York Times 07/17/2009
Advances Elusive in the Drive to Cure Cancer
New York Times 04/24/2009
Research and Development approaches of different pharmaceutical companies.
06/07/2006
As the R&D efforts of pharmaceutical companies become less productive new ways are being explored to develop new drugs for disease.
Grouped Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Research Chief Stirs Up Merck By Seeking Aid From Outsiders
Wall Street Journal 06/07/2006
Firms Study Drugs to Help Avert Diabetes - WSJ.com
Wall Street Journal 10/13/2006
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
BusinessWeek 12/05/2007
Sanofi Overhauls R&D To Help Costs, Pipeline
Wall Street Journal 07/01/2009
Pfizer.
01/19/2006
Grouped Articles
Wall Street Journal 01/19/2006
Weak Sales Prompt Pfizer to Cancel Diabetes Drug
New York Times 10/19/2007
Pfizer Unit, UCB Form a Venture
Wall Street Journal 10/21/2008
Drug Makers, Facing Critics, Will Stop Some Ads
Wall Street Journal 12/11/2008
Pfizer Plans to Lay Off Up to 2,400 in Sales
Wall Street Journal 01/17/2009
Pfizer Deal to Buy Wyeth Leaves Doubts
Wall Street Journal 01/27/2009
Pharmaceutical research and development in cancer drugs.
09/02/2009
Grouped Articles
Taking Risk for Profit, Industry Seeks Cancer Drugs
New York Times 09/02/2009
Glaxo Tries Biotech Model to Spur Drug Innovations
Wall Street Journal 07/01/2010
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us